Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Imiquimod 3.75% After Cryotherapy for Hypertrophic AK
NCT01229319Phase 4Unknown
- Start
- Oct 2010
- Primary completion
- Aug 2011
- Modality
- Nucleic Acid-Directed Small Molecules, Irreversible Covalent Inhibitors, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 4 trial of imiquimod in actinic keratosis (AK). Status: unknown.
02
Drugs
imiquimod
03
Conditions
actinic keratosis (AK)
Beyond the preview
Go deeper on NCT01229319.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01229319.